| Multiple hepatic debulking surgeries |
2 (7.1%) |
4 (5.0%) |
1 |
| Median # of hepatic lesions visualized preoperatively on CT or MRI |
10 (0-100) |
9 (0-85) |
.68 |
| Median % of liver parenchyma replaced by tumor |
19% (1-50) |
10% (0-55%) |
.08 |
| Bilobar hepatic disease |
23 (82.1%) |
63 (78.8%) |
.91 |
| Median % of liver disease debulked |
75% (13-100%) |
80% (0-100) |
.37 |
| # achieved 70% cytoreduction |
18 (64.3%) |
51 (63.8%) |
1 |
| # achieved 90% cytoreduction |
10 (35.7%) |
32 (40.0%) |
.86 |
| Type of liver procedures performed |
|
|
|
| Enucleation or wedge only |
6 (21.4%) |
17 (21.3%) |
1 |
| Ablation only |
4 (14.3%) |
6 (7.5%) |
.49 |
| Resection only |
0 |
1 (1.3%) |
0 |
| Enucleation/wedge + ablation |
16 (57.1%) |
53 (66.3%) |
.53 |
| Enucleation/wedge + ablation + resection |
1 (3.7%) |
0 |
.581 |
| Enucleation/wedge + resection |
1 (3.6%) |
3 (3.8%) |
1 |
| Median # of hepatic lesions treated |
6 (1-19) |
6 (0-36) |
.96 |
| Primary resected at time of liver surgery |
27 (96.4%) |
64 (80.0%) |
.08 |
| Median length of stay (days) |
8 (5-17) |
7 (5-24) |
.83 |
| Biochemical response (CgA, PST, NKA) |
|
|
|
| Nonresponder |
5 (25%) |
18 (32.1%) |
.75 |
| Biochemical response |
15 (75%) |
43 (70.5%) |
1 |
